Namspas Tablet
Images are for reference. Actual packaging may vary.
Dicyclomine (10mg) + Mefenamic Acid (250mg)
Strip of 10 tablets • Tablet
A valid prescription is required for this medicine.
Alternative MRP ₹30.6210% off MRP
Compare pack sizes and check with your doctor or pharmacist before switching medicines.
Active composition
+1 more active ingredient
Mefenamic acid inhibits cyclooxygenase (COX) enzymes, leading to decreased synthesis of prostaglandins, which mediate pain and inflammation.
Dicyclomine inhibits acetylcholine at muscarinic receptors, leading to relaxation of smooth muscle in the gastrointestinal tract.
Medical applications
Namspas Tablet is a combined pharmaceutical entity containing Dicyclomine (10mg) and Mefenamic Acid (250mg). This medication is primarily indicated for the relief of irritable bowel syndrome (IBS) symptoms, such as abdominal cramps, bloating, and diarrhea. The Dicyclomine component helps to reduce intestinal spasms, while Mefenamic Acid provides anti-inflammatory and analgesic effects, assisting in managing associated pain and inflammation.
It is essential to follow the prescribed dosage, as directed by a healthcare professional, for effective symptom management and minimizing potential side effects. Consult a healthcare provider for proper guidance on usage, especially for individuals with pre-existing medical conditions or those who are pregnant, breastfeeding, or taking other medications.
How to use Namspas Tablet Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Namspas Tablet is to be taken with food.
Important precautions
Side-effect information is not available for this medicine. Please consult your doctor or pharmacist.
Caution is advised when consuming alcohol with Namspas Tablet. Please consult your doctor.
High Risk
Information regarding the use of Namspas Tablet during pregnancy is not available. Please consult your doctor.
Medical Advice
It is not known whether Namspas Tablet alters the ability to drive. Do not drive if you experience any symptoms that affect your ability to concentrate and react.
Exercise Caution
Namspas Tablet should be used with caution in patients with liver disease. Dose adjustment of Namspas Tablet may be needed. Please consult your doctor.
Regular Checkup
Information regarding the use of Namspas Tablet during breastfeeding is not available. Please consult your doctor.
Consult Doctor
Namspas Tablet should be used with caution in patients with kidney disease. Dose adjustment of Namspas Tablet may be needed. Please consult your doctor. Use of Namspas Tablet is not recommended in patients with severe kidney disease.
Regular Checkup
0 reviews for Namspas Tablet






